Market Research Size

Tuesday, 12 January 2021

Magnetic Resonance Imaging Market to Incur Meteoric Growth During 2021 to 2028: Grand View Research Inc.

MRI Market Growth & Trends

The global magnetic resonance imaging market size is expected to reach USD 8.5 billion by 2028. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. The growing prevalence of chronic diseases and increasing demand for early diagnostic techniques are the factors expected to drive the market. In addition, the growing adoption of less invasive procedures is also contributing to the growth of the market. Moreover, the growing number of clinical trials to understand the effectiveness and efficiency of magnetic resonance imaging (MRI) machines in various clinical applications is also expected to boost market growth.

End-users such as research institutes and universities are frequently studying the efficiency of MRI devices with high field strength such as 7T, 10T, and 10.5T. The growing number of research studies will help in unlocking the potential usage and advantages of high field MRI machines for various preclinical as well as clinical applications. Currently, 7T MRI machines are only effective in brain and knee imaging, largely due to the absence of advance coil required for these high field machines. Therefore, the development of advance coils to expand the application of 7T MRI machines is expected to propel market growth during the forecast period.

Key market players are adopting various strategies such as mergers and acquisitions, collaborations, and partnerships to be competitive in the market. Aurora Imaging Technology entered into a distribution agreement with Sumec Group Corporation. Under this distribution agreement, Sumec Corporation will distribute MRI portfolio ofAurora Imaging Technology in China. This, in turn, is helping both the companies in geographical expansion.

Request a free sample copy or view report summary: MRI Market Report

MRI Market Report Highlights

Adoption of advanced imaging technologies is augmenting the growth of the market
Open system is anticipated to be the fastest growing segment during the forecast period due to its efficiency to accommodate all size of patients without feeling claustrophobic
MRI for neurological and brain disorders dominated the market largely due to growing number of neurological conditions and increasing demand for less invasive diagnostic procedure
The high field segment is expected to experience fastest growth largely due to its efficiency to provide detailed images for diagnosis
Ambulatory surgical centers are expected to exhibit highest growth rate during the forecast period. Government initiatives to improve primary care is one of the major factor impacting the segment growth
In 2020, North America dominated the magnetic resonance imaging (MRI) market and accounted for the largest revenue share owing to continuous research and high adoption of advanced techniques in the region
Asia Pacific is anticipated to witness the fastest growth rate over the forecast period due to growing number of clinical studies in the region for high field MRI machines

MRI Market Segmentation

Grand View Research has segmented the global magnetic resonance imaging market based on architecture, field strength, application, end-use, and region:

MRI Architecture Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

Closed System
Open System

MRI Field Strength Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

Low Field Strength
Mid Field Strength
High Field Strength

MRI Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

Brain and neurological
- Low Field Strength
- Mid Field Strength
- High Field Strength
Spine and musculoskeletal
- Low Field Strength
- Mid Field Strength
- High Field Strength
Vascular
- Low Field Strength
- Mid Field Strength
- High Field Strength
Abdominal
- Low Field Strength
- Mid Field Strength
- High Field Strength
Cardiac
- Low Field Strength
- Mid Field Strength
- High Field Strength
Breast
- Low Field Strength
- Mid Field Strength
- High Field Strength
Other
- Low Field Strength
- Mid Field Strength
- High Field Strength

MRI End-use Outlook (Revenue, USD Million, 2016 - 2028)

Hospitals
Imaging Centers
Ambulatory Surgical Centers
Others

MRI Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- Italy
- France
- Spain
- Sweden
- Russia
- The Netherlands
- Austria
- Belgium
- Denmark
- Norway
- Portugal
- Finland
Asia Pacific
- India
- China
- Japan
- Thailand
- South Korea
- Singapore
- Malaysia
- Philippines
- Taiwan
- Indonesia
- Vietnam
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Qatar

List of Key Players of Magnetic Resonance Imaging Market

GE Healthcare
Hitachi Medical Systems America AG.
Siemens AG
Toshiba Corporation
Aurora Imaging Technologies, Inc.
Koninklijke Philips N.V.
Esaote SPA
Sanrad Medical Systems Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Extracorporeal Membrane Oxygenation Machine Market is Thriving USD 398.6 Million Revenue by 2028

Extracorporeal Membrane Oxygenation Machine Market Growth & Trends

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.

According to the WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the growth.

The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth. Applications of ECMO machine procedures have been increased over the years. ECMO machine was traditionally used in cases of circulatory or respiratory failure. Its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.

The ECMO machine use has been rising gradually worldwide owing to its benefits such as artificial lung for the patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is adding growth to the market. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011. Major players in the market are focusing on technological collaboration and product launches.

Request a free sample copy or view report summary: Extracorporeal Membrane Oxygenation Machine Market Report

Extracorporeal Membrane Oxygenation Machine Market Report Highlights

North America accounted for the largest share in 2020 owing to favorable reimbursement policies, the presence of key players, and government initiatives
By component, the oxygenator segment accounted for the largest share in 2020 owing to its high cost and usage
In terms of modality, the veno-arterial segment accounted for the largest share in 2020 and is expected to grow at the fastest rate during the forecast period
Based on patient type, the adult segment is expected to grow at a rapid pace during the forecast period owing to the rising incidence of cardiac and pulmonary diseases
On the basis of application, the respiratory segment held the largest market share in 2020 and is expected to grow at the fastest rate over the forecast period

Extracorporeal Membrane Oxygenation Machine Market Segmentation

Grand View Research has segmented the global extracorporeal membrane oxygenation machine market on the basis of component, modality, patient type, application, and region:

ECMO Machine Component Outlook (Revenue, USD Million, 2016 - 2028)

Pumps
Oxygenator
Controllers
Cannula
Accessories

ECMO Machine Modality Outlook (Revenue, USD Million, 2016 - 2028)

Veno-Arterial
Veno-Venous
Arterio-Venous

ECMO Machine Patient Type Outlook (Revenue, USD Million, 2016 - 2028)

Neonates
Pediatric
Adult

ECMO Machine Application Outlook (Revenue, USD Million, 2016 - 2028)

Respiratory
- Neonates
- Pediatric
- Adult
Cardiac
- Neonates
- Pediatric
- Adult
ECPR
- Neonates
- Pediatric
- Adult

ECMO Machine Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
- Czech Republic
- Russia
- Poland
- Turkey
- Switzerland
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Vietnam
- Philippines
- Malaysia
- Indonesia
- Thailand
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Oman
- Kuwait

List of Key Players of Extracorporeal Membrane Oxygenation Machine Market

Medtronic plc
Sorin Group
Terumo Cardiovascular Systems Corporation
MAQUET Holding B.V. & Co. KG
Medos Medizintechnik AG
Nipro Medical Corporation
Microport Scientific Corporation

About Grand View Research

Monday, 11 January 2021

Medical Imaging Market Trends Regulations And Competitive Landscape Outlook to 2028

Medical Imaging Market Growth & Trends

The global medical imaging market size is expected to reach USD 28.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. Increasing demand for advanced diagnostic systems in developing countries and growing trends of market player collaborations are some of the key factors driving the market.

Developing countries have shown a surge in the volume of imaging procedures in the past few years. The low density of installed imaging systems in these regions is expected to provide significant growth potential during the forecast period. Favorable government policies and booming medical tourism in these countries are expected to attract global market players in the untapped market.

The integration of multiple imaging modalities is expected to play an important role in market growth. These systems have accurate diagnostic capabilities and are available at affordable prices. The integration of imaging modalities with surgical suites is anticipated to open a new avenue for the market at the global level.

The development of portable diagnostic tools is important to expand the applications of imaging devices in ambulatory care, clinics, and emergency care departments. Handheld ultrasound devices provide quick and safer images that are critical in emergency care.

Ongoing trials and studies to explore the potential of MRI technology for the early detection of neurological conditions are showing positive results. The development of new radiofrequency coils is anticipated to expand these applications during the forecast period.

Request a free sample copy or view report summary: Medical Imaging Market Report

Medical Imaging Market Report Highlights

By product, the ultrasound segment captured the largest share in 2020 and is expected to dominate throughout the forecast period. Computed tomography is expected to grow at the fastest rate during the forecast period due to rapid technological advancements, such as the development of hybrid imaging modalities and the integration of AI
Based on end use, the hospital's segment dominated the market in 2020 due to the blooming healthcare service industry in developing countries. The ambulatory imaging centers segment is anticipated to witness the fastest growth during the forecast period
North America captured the largest market share in 2020 due to the presence of a large number of industry players and the high frequency of new product launches

Medical Imaging Market Segmentation

Grand View Research has segmented the global diagnostic imaging market on the basis of product, end use, and region:

Medical Imaging Product Outlook (Revenue, USD Million, 2016 - 2028)

X-ray
- By Modality
  - Radiography
  - Fluoroscopy
  - Computed Radiography
- By Mobility
  - Stationary
  - Mobile
- By Product
  - Digital
  - Analog
- By Application
  - General radiology
  - Dental
  - Breasts
  - Cardiology
  - Others
- Ultrasound
  - By Product
    - 2D
    - 3D/4D
    - Doppler Ultrasound Devices
  - By Portability
    - Handheld
    - Cart/Trolley Based
  - By Application
    - Ob/Gyn
    - Cardiovascular
    - Musculoskeletal
    - Others
  - Computed Tomography
    - By Technology
      - High-end slice
      - Mid-end slice
      - Low-end slice
      - Cone beam
    - By Application
      - Oncology
      - Neurology
      - Cardiology
      - Vascular
      - Musculoskeletal
      - Others
    - Magnetic Resonance Imaging
      - By Architecture
        
        Closed System
        
        Open System
      - By Field Strength
        
        Low Field Strength
        
        Mid Field Strength
        
        High Field Strength
      - By Application
        
        Brain and neurological
        
        Spine and musculoskeletal
        
        Vascular
        
        Abdomen
        
        Cardiac
        
        Breast
        
        Other
      - Nuclear Imaging
        
        By Product
        
        SPECT
        
        Hybrid SPECT
        
        Standalone SPECT
        
        Hybrid PET
        
        Planar Scintigraphy
        
        By Application
        
        Oncology
        
        Cardiology
        
        Neurology
        
        General Imaging

Medical Imaging End-use Outlook (Revenue, USD Million, 2016 - 2028)

Hospitals
Diagnostic Imaging Centers
Ambulatory Imaging Centers
Others

Medical Imaging Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Italy
- Spain
- Russia
- Netherlands
- Switzerland
- Turkey
- Poland
Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Malaysia
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Iran

List of Key Players of Medical Imaging Market

GE Healthcare
Koninklijke Philips N.V.
Siemens Healthineers
CANON MEDICAL SYSTEMS CORPORATION
Bruker
Mediso Ltd.
MILabs B.V.
MR Solutions
TriFoil Imaging
PerkinElmer Inc.
FUJIFILM VisualSonics Inc.
Cubresa Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aesthetic Medicine Market Industry Size, Driving Demands, and Industry Share of Various Stakeholders

Aesthetic Medicine Market Growth & Trends

The global aesthetic medicine market size is expected to reach USD 124.7 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.8% from 2021 to 2028. According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is ‘a branch of medicine focused on satisfying the aesthetic desires and goals of patient. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Key drivers of the market include introduction of non-invasive medical devices for cosmetic procedures, growing focus on physical appearance, and rise in adoption among geriatric individuals.

Based on procedure type, the market is mainly divided into invasive and non-invasive procedures. Invasive procedures include breast augmentation, liposuction, and nose reshaping while non-invasive procedures include popular technology such as Botox injections, soft tissue fillers, and chemical peel. Rise in number of obesity cases in the U.S. has urged patients to opt for cosmetic treatments in the country.

In Asia Pacific, rise in income level of the adult population in countries such as China and India is expected to create lucrative opportunity for the market. The region is also backed by South Korea, which is the hub of cosmetic surgeries.

Request a free sample copy or view report summary: Aesthetic Medicine Market Report

Aesthetic Medicine Market Report Highlights

The non-invasive procedures segment is projected to dominate throughout the forecast period owing to its quicker and accurate results along with ease of usage compared to invasive procedures
Breast augmentation and liposuction are among the fastest growing under the invasive procedures segment in the forecast years
In Asia Pacific, the market is projected to witness a CAGR of 10.9% during the forecast period. Countries such as South Korea and India are expected to serve as key revenue pockets

Aesthetic Medicine Market Segmentation

Grand View Research has segmented the global aesthetic medicine market on the basis of procedure type and region:

Aesthetic Medicine Procedure Type Outlook (Revenue, USD Million, 2016 - 2028)

Invasive Procedures
- Breast augmentation
- Liposuction
- Nose reshaping
- Eyelid Surgery
- Tummy tuck
- Others
Non-invasive Procedures
- Botox injections
- Soft tissue fillers
- Chemical peel
- Laser hair removal
- Microdermabrasion
- Others

Aesthetic Medicine Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
Latin America
- Brazil
- Mexico
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE

List of Key Players of Aesthetic Medicine Market

Allergan Inc.
Hologic (cynosure)
Johnson & Johnson
Galderma
Lumenis
Solta Medical
Syneron Candela
Alma Laser

About Grand View Research

Neurothrombectomy Devices Market Expected to Deliver Dynamic Progression until By 2028

Neurothrombectomy Devices Market Growth & Trends

The global neurothrombectomy devices market size is anticipated to reach USD 1.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. Increasing incidence of acute is chemic stroke, such as intracerebral and subarachnoid hemorrhagic stroke is anticipated to boost the market growth. For instance, according to the Stroke Alliance for Europe, the stroke incidence rate in Europe will increase by 34.0% from 2015 to 2035.

Furthermore, stroke remains the leading cause of death worldwide due to the adoption of a morbid lifestyle. For instance, in the U.S., around 70,000 stroke incidences are reported each year, out of which 23.0% are fatal or cause permanent disability. Moreover, smoking is another foremost risk factor responsible for ischemic or hemorrhagic stroke.

Technological advancements play a crucial role in driving the market. For instance, Medtronic’s Solitaire Platinum Revascularization neurothrombectomy device comprises of nitinol scaffolding design attached to a pushwire. This medical instrument is designed to reduce around 70.0% of stroke-related disability and to improve the functional outcome at 90 days in patients suffering a large vessel occlusion.

Request a free sample copy or view report summary: Neurothrombectomy Devices Market Report

Neurothrombectomy Devices Market Report Highlights

On the basis of product, the clot retrievers segment dominated the market in 2020 and accounted for a revenue share of 58.3% owing to an increasing number of patients suffering from acute ischemic stroke due to large vessel occlusion
Based on end use, the hospital segment dominated the market in 2020 and accounted for the largest revenue share of 70.9% owing to the rising incidence of strokes and growing awareness regarding neurothrombectomy procedures
However, ambulatory surgical centers is anticipated to be the fastest-growing segment over the forecast period. This is attributed to a shorter waiting time that ASCs provide to the patients and an increasing number of ASC facilities
Europe dominated the market with the highest revenue share of 32.2% in 2020 and is expected to witness the highest CAGR owing to the presence of well-developed healthcare facilities and favorable reimbursement policies

Neurothrombectomy Devices Market Segmentation

Grand View Research has segmented the global neurothrombectomy devices market on the basis of product, end use, and region:

Neurothrombectomy Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

Clot Retrievers
Aspiration/Suction Devices
Vascular snares

Neurothrombectomy Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

Hospitals
Emergency Clinics
Ambulatory Surgical Centers

Neurothrombectomy Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
Latin America
- Mexico
- Brazil
- Argentina
- Colombia
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE

List of Key Players of Neurothrombectomy Devices Market

Medtronic
Stryker Corporation
Acandis GmbH
Stryker
Phenox GmbH
Penumbra Inc.
Vesalio

About Grand View Research

COVID-19 Clinical Trials Market Poised to Expand at a Robust Pace of USD 9.9 Billion Over 2027: Grand View Research Inc.

COVID-19 Clinical Trials Market Growth & Trends

The global COVID-19 clinical trials market size is expected to reach USD 9.9 billion by 2027, registering a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. An increasing number of deaths due to coronavirus is creating a need to develop effective treatments, thereby boosting the market growth. Also, the underlying economic profits for first movers are encouraging pharmaceutical players to invest in clinical trial studies for COVID-19.

The current pandemic poses an acute health risk to the entire population. A key to successfully fighting COVID-19 lies in clinical research. At present, almost all the major research-based pharmaceutical companies, many other biotechnology and pharmaceutical companies, as well as research institutes are engaged in a race to develop an effective treatment against coronavirus. There are currently 661 unique compounds in development against COVID-19, of which 292 are drugs, 173 are vaccines and 196 are antivirals.

The regulators in the U.S. and Europe also offer various options for action and procedural facilitation to enable faster access to effective vaccines and drugs to combat the pandemic. In March 2020, the Solidarity Trial-an international clinical trial by the World Health Organization (WHO)-was launched to find effective treatment against COVID-19. In May 2020, WHO also announced an international alliance for developing various candidate vaccines to stop the spread of coronavirus disease, calling this effort the Solidarity trial for vaccines.

The current scenario across the globe and the need to come up with treatment options has also led to the fast-track of clinical trials. Hence, in March 2020, the Food and Drug Administration (FDA) launched a Coronavirus Treatment Acceleration Program (CTAP) for the likely therapies to accelerate the development of the treatment for the pandemic caused by a coronavirus. Recently in May 2020, the U.S. FDA granted fast track title to Moderna’s mRNA vaccine candidate, mRNA-1273, to protect against COVID-19.

Request a free sample copy or view report summary: COVID-19 Clinical Trials Market Report

COVID-19 Clinical Trials Market Report Highlights

Phase II COVID-19 clinical trials dominated the market with a share of 35.0% in 2020. This is attributed to the maximum number of products currently in development.
The vaccines segment accounted for the largest share of 77.1% in 2020 owing to the increasing investments towards it.
Europe held 46.8% of the market share in 2020. Favorable government initiatives such as the UK’s “ACCORD” clinical trial program are contributing to market growth.
The Asia Pacific region is projected to witness the fastest CAGR of 11.8% during the forecast period as the increasing number of biotechnology firms are looking at the region for their COVID-19 trials to take advantage of the large patient pool and fast-track procedures.

COVID-19 Clinical Trials Market Segmentation

Grand View Research has segmented the global COVID-19 clinical trials market based on phase, product, and region:

COVID-19 Clinical Trials Market Phase Outlook (Revenue, USD Million, 2016 - 2027)

Phase I
Phase II
Phase III
Phase IV
Others

COVID-19 Clinical Trials Market Product Outlook (Revenue, USD Million, 2016 - 2027)

Therapeutics
Vaccines

COVID-19 Clinical Trials Market Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America
- The U.S.
- Canada
Europe
- The U.K.
- Germany
- France
- Spain
- Italy
Asia Pacific
- India
- Japan
- China
- Australia
- South Korea
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
The Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

List of Key Players of COVID-19 Clinical Trials Market

Moderna, Inc.
GlaxoSmithKline plc
Pfizer Inc.
Johnson & Johnson
Gilead Sciences Inc.
INOVIO Pharmaceuticals
AbbVie Inc.
BioNTech SE
Novavax
Takeda

About Grand View Research

Ecotoxicological Studies Market to Reach Around USD 1.3 Billion by 2027: Grand View Research Inc.

Ecotoxicological Studies Market Growth & Trends

The global ecotoxicological studies market size is expected to reach USD 1.3 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.6% from 2021 to 2027. Ecotoxicological studies are conducted to estimate the effects of toxic substances on an ecosystem and are based on scientific research by both laboratory and field methods. The growth of the pharmaceutical and biopharmaceutical industries is likely to drive the market. Stringent regulatory requirements and favorable government support are further contributing to market growth. Most regulatory authorities require ecotoxicity testing using various organisms. The U.S. Environmental Protection Agency (EPA) recommends specific tests, organisms, and toxicity endpoints to calculate the risk from Plant Protection Products (PPPs), such as pesticides, and has developed guidelines for ecological risk assessments to assess the likelihood of plant and wildlife toxicity as well as environmental fate.

The increasing number of chemicals such as synthetic hormones and pharmaceuticals are used on a daily basis all over the world. In Europe, approximately 100,000 chemicals are currently used during the manufacturing of drugs. With the exception of pesticides that are released into the environment purposely, many chemicals enter the environment due to their use through different paths. Hence, to assess risks from chemicals to the ecosystem, toxicity data on chemicals is required.

Ecotoxicological studies are conducted and reported as per the globally validated standard test guiding principles and Good Laboratory Practices (GLPs). For instance, GPLs provided by the U.S. Environmental Protection Agency (EPA) and Organization for Economic Co-operation and Development (OECD) are required by many regulatory frameworks for environmental or ecological hazard and risk assessment of chemicals. There are various documents that include requirements of environmental safety, such as the Biocidal Product Directive (BPR), OSPAR, and European REACH regulation.

Request a free sample copy or view report summary: Ecotoxicological Studies Market Report

Ecotoxicological Studies Market Report Highlights

Based on service, the aquatic ecotoxicology segment dominated the market with a share of 43.6% in 2020 as major regulatory bodies across the globe mandate evidence of the potential hazard of drugs to aquatic organisms and ecosystems
The sediment ecotoxicology service segment is expected to expand at the highest CAGR of 3.9% over the forecast period as sediment ecotoxicology studies are conducted on a large scale by pharmaceutical companies. Sediments can adsorb persistent pollutants and thereby act as a long-term source of pollution for surface water
Europe dominated the market in 2020 with a share of 34.0% due to the favorable government support and the presence of various regulatory bodies, such as the European Chemical Agency (ECHA); Registration, Evaluation, Authorization and Restriction of Chemicals (REACH); and the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Polymers Task Force
Asia Pacific is anticipated to register the highest CAGR over the forecast period owing to the improved regulatory frameworks, the high scope for cost savings, and growing industrialization leading to the establishment of pharmaceutical companies in the region

Ecotoxicological Studies Market Segmentation

Grand View Research has segmented the global ecotoxicological studies market based on service and region:

Ecotoxicological Studies Service Outlook (Revenue, USD Million, 2016 - 2027)

Aquatic Ecotoxicology
Sediment Ecotoxicology
Terrestrial Ecotoxicology
Avian Ecotoxicology
Pollinator Testing

Ecotoxicological Studies Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
Asia Pacific
- India
- China
- Japan
- Australia
- South Korea
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

List of Key Players of Ecotoxicological Studies Market

Smithers
SGS SA
Covance, Inc.
INTOX Pvt. Ltd.
Fera Science Limited
Charles River Laboratories
Noack Laboratorien GmbH
Eurofins Agroscience Services Group

About Grand View Research

Electric Bed Market is Anticipated To Generate Significant Revenues by 2027: Grand View Research Inc.

Electric Bed Market Growth & Trends

The global electric bed market size is expected to reach USD 3.80 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2021 to 2027. The increasing number of accident cases across the globe, the growing geriatric population, the rising number of surgical procedures globally, and the recent outbreak of COVID-19 are the key factors driving the market.

The number of road accidents is rapidly increasing, leading to a rise in the need for electric beds in hospitals and clinics. For instance, according to the Association for Safe International Road Travel (ASIRT), around 20.00 to 50.00 million people are injured or disabled every year. Road traffic accidents are the 9th leading cause of death worldwide. ASIRT also reported that in the U.S., more than 37,000 people die in road accidents per year and around 2.35 million are injured or disabled. In some cases, road accidents require immediate surgery and care, and thus in such cases, an electric bed is one of the essential requirements.

As per the Ministry of Road Transport and Highways, Government of India, in 2016, around 494,624 people were injured in road accidents. This number has increased by 25.6% from 2007 to 2017. In 2016, the states that recorded the highest number of road accidents were Uttar Pradesh (25,096), Tamil Nadu (82,163), Maharashtra (35,884), and Karnataka (54,556). Therefore, such instances indicate considerable growth of the market over the forecast period. In addition, the growing geriatric population, which is more susceptible to various diseases, and increasing hospital admissions are anticipated to propel the market growth. For instance, as per the U.S. Census Bureau, the number of people aged 65 or older increased by 1.6 million from 2015 to 2016. Hence, the increasing geriatric population is also expected to propel the market growth over the forecast period.

Request a free sample copy or view report summary: Electric Bed Market Report

Electric Bed Market Report Highlights

In terms of product, the semi-automatic electric bed segment held the largest share in 2020. The increasing number of hospital admissions across the globe is expected to fuel the segment growth over the forecast period
Based on application, the general bed segment held the largest market share in 2020 owing to the rising number of accident cases across the globe
By end use, the hospitals and clinics segment is anticipated to witness the fastest growth over the forecast period owing to the increasing number of hospital admissions due to the recent outbreak of COVID-19
Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the rising number of surgeries and the presence of many local key players

Electric Bed Market Segmentation

Grand View Research has segmented the global electric bed market on the basis of product, application, end use, and region:

Electric Bed Product Outlook (Revenue, USD Million, 2015 - 2027)

Semi-automatic Electric Bed
Fully Automatic Electric Bed

Electric Bed Application Outlook (Revenue, USD Million, 2015 - 2027)

General Bed
Intensive Care Bed
Bariatric Bed
Birthing Bed
Others

Electric Bed End-use Outlook (Revenue, USD Million, 2015 - 2027)

Hospitals & Clinics
Reproductive Care Centers
Dentistry
Others

Electric Bed Regional Outlook (Revenue, USD Million, 2015 - 2027)

North America
- US.
- Canada
Europe
- UK.
- Germany
Asia Pacific
- Japan
- China
Latin America
- Brazil
- Mexico
MEA
- South Africa
- Saudi Arabia

List of Key Players of Electric Bed Market

Arjo
Hill-Rom Services Inc.
Medline Industries, Inc.
Paramount Bed Co., LTD.
Invacare Corporation
Stryker
Malvestio Spa
LINET
Gendron Inc.
Midmark India Pvt. Ltd.

About Grand View Research

Sunday, 10 January 2021

Filter Needles Market Latest Innovations, Drivers and Industry Key Events 2021– 2027: Grand View Research Inc.

Filter Needles Market Growth & Trends

The global filter needles market size is expected to reach USD 2.3 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.2% from 2021 to 2027. The increasing geriatric population, technological advancements, and rising prevalence of chronic wounds are the key factors driving the market. The increasing prevalence of various chronic wounds across the globe is anticipated to drive the market over the forecast period. Some of the prevailing chronic wounds are diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Diabetic foot ulcers generally occur due to prolonged diabetes or low blood glucose level in patients. The increasing rate of diabetes in all age groups across the globe is a major factor responsible for the high prevalence of diabetic foot ulcers. As per studies conducted by the National Center for Biotechnology Information (NCBI), in 2017, the prevalence rate of diabetic foot ulcers in North America was 13.0% (highest), 5.5% in Asia, 7.2% in Africa, 5.1% in Europe, 1.5% in Australia, 16.6% in Belgium, 14.8% in Canada, and 13.0% in the U.S.

The incidence rate of pressure ulcers is rising owing to a rapidly aging population and an increase in the incidence of disabilities across the globe. In the U.S., around USD 11.0 billion is spent per year on pressure ulcers, as per the NCBI. Furthermore, the prevalence rate of pressure ulcers in nursing home patients is around 11.0% every year, therefore incidence and prevalence are anticipated to be high over the forecast period. A venous leg ulcer is an open lesion between the ankle joint and knees mainly caused due to venous disease. It is the most common leg ulcer and the prevalence rate of venous leg ulcers ranges from 0.18% to 1.0%, as per NCBI. Venous leg ulcers are the most advanced form of chronic venous disorders and the recurrence rate of these ulcers is more than 70.0%. Such a high prevalence of chronic wounds is expected to boost market growth over the forecast period.

Request a free sample copy or view report summary: Filter Needles Market Report

Filter Needles Market Report Highlights

In terms of revenue, the stainless steel segment held the largest market share in 2020 due to the presence of several players offering this product and low price
The hospitals segment held the largest revenue share in 2020 owing to the increasing number of hospitals across the globe
In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period owing to the rising road accident cases in this region

Filter Needles Market Segmentation

Grand View Research has segmented the global filter needles market on the basis of raw material, end-use, and region:

Filter Needles Raw Material Outlook (Revenue, USD Million, 2016 - 2027)

Stainless Steel
Glass
Others

Filter Needles End-use Outlook (Revenue, USD Million, 2016 - 2027)

Hospitals
Clinics
Ambulatory Surgery Centers
Others

Filter Needles Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America
- US.
- Canada
Europe
- UK
- Germany
Asia Pacific
- Japan
- China
Latin America
- Brazil
- Mexico
MEA
- South Africa
- Saudi Arabia

List of Key Players of Filter Needles Market

BD
Cardinal Health
Sentra Medical
Myco Medical
Stryker
Braun Melsungen AG
SOL-Millennium

About Grand View Research

COVID-19 Drug Delivery Devices Market Pegged For Strong Growth During 2021-2027: Grand View Research Inc.

COVID-19 Drug Delivery Devices Market Growth & Trends

The global COVID-19 drug delivery devices market size is expected to reach USD 2.15 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2022 to 2027. The market is expected to gain significant traction over the forecast period as various nasal drug delivery technologies for administrating COVID-19 vaccines are under clinical and pre-clinical development. For instance, in April 2020, Verndari, Inc. initiated the preclinical trials for coronavirus vaccine using its patented microneedle array dermal patch- VaxiPatch.

The nasal, dermal, and needle-free are alternatives to the traditional syringe vaccine platforms. These devices potentially reduce or eliminate needlestick injuries and reduce the associated treatment costs. According to the research article published in PLUS ONE Journal, November 2019, needlestick injury (NSI) is among a major burden in medical settings, leading to the transmission of infectious diseases, such as hepatitis and HIV.

According to the article published in StatPearls publishing, December 2019, around 2-4% of healthcare workers develop hepatitis C after suffering from needlestick injuries. The CDC further stated that needlestick injuries cost an estimated USD 3,042 per victim annually in the U.S.

Request a free sample copy or view report summary: COVID-19 Drug Delivery Devices Market Report

COVID-19 Drug Delivery Devices Market Report Highlights

North America is anticipated to capture the largest share in 2021 owing to growing investment by government organizations for vaccine development, the surge in COVID-19 cases, and intensive R&D conducted by the key players
By product, the prefilled syringe segment is expected to dominate the market in 2021 as these cost-effective delivery devices will be manufactured in bulk quantities for vaccine administration and will be the first among the approved products
By route of administration, the parenteral segment is expected to dominate the market in 2021 as the injection devices are affordable and are among the easily available devices
By distribution channel, the hospital pharmacies segment is expected to account for the largest market share in 2021 as these drug delivery devices require medical assistance for vaccine administration
Market players are adopting several strategies such as significant investment in research and development and product innovation via collaborations with technology providers and universities to gain a significant share in the global market.

COVID-19 Drug Delivery Devices Market Segmentation

Grand View Research has segmented the global COVID-19 drug delivery devices market based on the product, route of administration, distribution channel, and region:

COVID-19 Drug Delivery Devices Product Outlook (Revenue, USD Million, 2020 - 2027)

Prefilled Syringe
Needle-free Injectors
Inhalers
Patch

COVID-19 Drug Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2020 - 2027)

Parenteral
Nasal
Dermal

COVID-19 Drug Delivery Devices Distribution Channel Outlook (Revenue, USD Million, 2020 - 2027)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

COVID-19 Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2020 - 2027)

North America
- The U.S.
- Canada
Europe
- The U.K.
- Germany
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

List of Key Players of COVID-19 Drug Delivery Devices Market

AstraZeneca
Johnson & Johnson
Serum Institute of India
GlaxoSmithKline plc
Moderna
Bharat Biotech
Pfizer
PharmaJet
Novawax, Inc.

About Grand View Research

Friday, 8 January 2021

U.S. Medical Device Manufacturers Market Is Expected To Accomplish A Valuation Of Around USD 262.4 Billion By 2028: Grand View Research Inc.

U.S. Medical Device Manufacturers Market Growth & Trends

The U.S. medical device manufacturers market size is expected to reach USD 262.4 billion by 2028 and is projected to expand at a CAGR of 5.0%, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.

The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.

Request a free sample copy or view report summary: U.S. Medical Device Manufacturers Market Report

U.S. Medical Device Manufacturers Market Report Highlights

Diagnostic imaging accounted for the largest revenue share of over 31% in 2020. Factors responsible for this estimated share include the rising need for early diagnosis of disease coupled with growing technological advancements in diagnostic imaging devices
In August 2020, B. Braun Medical Inc. received 510(k) clearance from the FDA for the SpaceStation MRI. This allows space infusion pumps to continuously deliver medications to patients within the MRI suite
The growing geriatric population and rising prevalence of chronic diseases are also driving the segment growth
Key players are ramping up consumable medical devices production to fulfill the sudden upsurge in demand accelerated by COVID-19
In 2020, Abbott Laboratories shipped over 7 million rapid ID NOW test kits, 6 million molecular lab test kits, and more than 13 million ARCHITECT and Alinity i Covid-19 antibody test kits to customers across the U.S.
The South Dakota-based plant of 3M went through a new 120,000 square-foot expansion in 2020 for achieving the production of 95 million N95 respirators per month by the end of the year

U.S. Medical Device Manufacturers Market Segmentation

Grand View Research has segmented the U.S. medical device manufacturers market on the basis of type:

U.S. Medical Device Manufacturers Type Outlook (Revenue, USD Billion, 2016 - 2028)

Diagnostic Imaging
Consumables
Patient Aids
Orthopedics
Others

List of Key Players of U.S. Medical Device Manufacturers Market

3M Healthcare
Abbott
Baxter International, Inc.
Braun Melsungen AG
GE Healthcare
Johnson & Johnson Services, Inc.
Medtronic PLC
Boston Scientific Corp.

About Grand View Research

End Stage Renal Disease Market to Reflect Robust Expansion During 2021-2028: Grand View Research Inc.

End Stage Renal Disease Market Growth & Trends

The global end stage renal disease market size is anticipated to reach USD 193.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.7% from 2021 to 2028. The increasing number of patients suffering from end stage renal disease (also known as kidney failure) and the rising prevalence of hypertension and diabetes are fueling the market growth.

Chronic kidney disease (CKD) is one of the major causes of increasing kidney failure rates among patients. According to the CDC, it is estimated that more than 37 million people in the U.S. suffer from CKD, whereas globally more than 500 million people (12-18% of the world population) are affected.

The COVID-19 pandemic has impacted the healthcare industry and people suffering from end stage renal disease (ESRD) are at a higher risk of contracting this virus as they have to visit the hospitals often for dialysis. Center-based hemodialysis is the main renal replacement medium in most countries, with almost 90% of the ESRD population opting for it. Hemodialysis patients have to stay in hospitals for 4 hours minimum, 3 times a week, and come in frequent contact with the medical staff and other patients. All these factors increase their risk of infection.

Technological advancements including the innovation of wearable artificial kidney (WAK) in the treatment of renal failure are expediting the overall market growth. WAK is a portable dialysis device designed to enable patients to live healthier as it controls blood pressure, improves clearance of wastes from the blood, and allows ESRD or CKD patients for a less strict diet, resulting in lower fluid weight gain in addition to lowered stress on the heart. Thus, technical advancements in WAK have the potential to reduce mortality in dialysis patients, which thereby improves an ESRD patient’s quality of life. The WAK prototypes designed and patented by innovative firms have been approved for human clinical trials by the U.S. FDA in 2016.

Request a free sample copy or view report summary: End Stage Renal Disease Market Report

End Stage Renal Disease Market Report Highlights

By treatment, the dialysis segment dominated the ESRD market in 2020 owing to its ease of use and emergency convenience
The transplant treatment segment is expected to expand at the highest CAGR from 2021 to 2028
Asia Pacific dominated the market in 2020 owing to the large population of patients with CKD/ESRD and greater incidence of hypertension and diabetes in the region

End Stage Renal Disease Market Segmentation

Grand View Research has segmented the global end stage renal disease market on the basis of treatment and region:

End-Stage Renal Disease Treatment Outlook (Revenue, USD Million, 2016 - 2028)

Transplant
Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable Artificial Kidney

End-Stage Renal Disease Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
Asia Pacific (APAC)
- Japan
- China
- India
- Australia
- South Korea
Latin America (LATAM)
- Mexico
- Brazil
- Argentina
- Colombia
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE

List of Key Players of End Stage Renal Disease Market

Nipro Corporation
Fresenius Medical Care AG & Co. KGaA
Baxter International, Inc.
Medtronic Plc
Braun Melsungen AG
BD
Asahi Kasei Medical Co., Ltd.
Cantel Medical
Nikkiso Co., Ltd.
JMS Co. Ltd.

About Grand View Research

India Online Grocery Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

India Online Grocery Market Growth & Trends

The India online grocery market size is projected to reach USD 38.9 billion by 2028, according to a study conducted by Grand View Research, Inc. It is expected to expand at a CAGR of 37.1% from 2021 to 2028. The online grocery market in India has been thriving with consumers favoring the convenience of online shopping over neighborhood grocery retailers. Amid the COVID-19 pandemic, people have been careful to step out from the safety of their homes.

A rising number of individuals are shifting toward online grocery shopping for meeting their needs during the time of social distancing. The online grocery market in India, while still in its nascent stage, witnessed remarkable growth during the pandemic period and is set to pick up significantly as social distancing becomes the new normal and as traditional grocery retailing loses appeal across hitherto experience. Additionally, growing smartphone usage, coupled with the proliferation of the internet, is a key factor expected sto boost market growth over the forecast period.

Furthermore, a rise in investments of Venture Capital and Private Equity (PE) funds into India's consumer internet and online retail sectors are likely to support the growth of the market. Moreover, in the coming years, the industry is expected to be driven by consumers using local languages over English from Tier-I as well as Tier-II and III cities. Hence, key players in the market are looking forward to adapting their platforms to local languages and establish improved voice search features to build their potential consumer base. Other appealing offers like fast delivery or same-day delivery, low delivery charges, cashback offers, and flexible return policies by online grocery platforms are also expected to drive the market in the foreseeable future.

Online grocery shopping is seen to be highly convenient and user-friendly; however, it has its challenges. A personalized experience, lack of physical evidence, and checking the product for its freshness before the purchase is absent while shopping online. The growing awareness of fitness and well-being, eating fresh and healthy food raises concerns about buying groceries online. Moreover, frauds associated while making an online purchase and payments, delays in the delivery, and delivery of damaged or expired goods are some of the other factors that are likely to hinder the market growth. Nevertheless, the adoption of the Internet of Things (IoT) is projected to provide lucrative opportunities for the market over the forecast period. IoT aids e-commerce companies keep track of their inventory with the use of IoT enabled devices within the network. These IoT-enabled devices help retailers provide real-time data and analyze the demand for several products across different regions and cities.

Request a free sample copy or view report summary: India Online Grocery Market Report

India Online Grocery Market Report Highlights

Based on product type, the staples and cooking essentials segment dominated the market with a share of 33.9% in 2020 owing to the constant shopping of staples
The online payment method segment is expected to expand at the fastest CAGR over the forecast period. India’s online grocery market, traditionally dominated by cash, is evolving to meet the demands of its increasingly smartphone-led online shopping culture, with cards and digital wallets rising in prominence
By region, South India accounted for 34.6% share in 2020 and is expected to witness significant growth over the coming years. The West India region is anticipated to witness the second-highest growth over the forecast period

India Online Grocery Market Segmentation

Grand View Research has segmented the India online grocery market on the basis of product type, payment method, and region:

India Online Grocery Product Type Outlook (Revenue, USD Million, 2017 - 2028)

Fresh Produce
Breakfast & Dairy
Snacks & Beverages
Meat & Seafood
Staples & Cooking Essentials
Others

India Online Grocery Payment Method Outlook (Revenue, USD Million, 2017 - 2028)

Online
Offline (Cash on Delivery)

India Online Grocery Regional Outlook (Revenue, USD Million, 2017 - 2028)

South India
North India
West India
East India

List of Key players of India Online Grocery Market

Amazon India Pvt. Ltd.
Godrej Nature's Basket Ltd.
Grofers India Pvt. Ltd.
Paytm E-Commerce Pvt. Ltd. (Paytm Mall)
Reliance Retail Ltd. (Reliance Fresh)
Spencer's Retail
Supermarket Grocery Supplies Pvt. Ltd. (BigBasket)
UrDoorstep eRetail Pvt. Ltd.

About Grand View Research

Fundus Cameras Market Competitive Insight and Key Drivers 2021 to 2028: Grand View Research Inc.

Fundus Cameras Market Growth & Trends

The global fundus cameras market size is expected to reach USD 470.4 million by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.8% from 2021 to 2028. The rising geriatric population and growing occurrences of chronic disorders such as diabetes and hypertension further increase the incidence of retinal disorders.

For instance, according to the WHO 2016 report, globally, in 2014, 422.0 million people had diabetes. Additionally, increasing non-communicable diseases such as AMD, diabetic retinopathy, and glaucoma is contributing to the growing blind population globally. Therefore, to control the impact of these eye diseases, the fundus camera is widely used for diagnosis purposes. Availability of different types of fundus cameras such as hybrid, portable, handheld, and standalone is expected to propel the market growth during the forecast period.

Diabetic Retinopathy (DR), Retinopathy of Prematurity (ROP), and Age-Related Macular Degeneration (AMD) are major and increasing causes of retinal blindness. An increase in life expectancy has led to a rise in the geriatric population, which would further continue to rise in the future. According to the U.S. Census Bureau, international database, the global geriatric population was nearly 617.1 million in 2015 and is anticipated to reach 998.7 by 2030. This, in turn, is expected to drive the overall market growth during the forecast period.

In addition, supportive government regulations for fundus cameras are expected to fuel the market growth during the forecast period. For instance, regulatory agencies in the U.S. and Japan stated that the cameras should be replaced every 4 years. This initiative by the agencies will help in implementing new advancements in fundus photography every 4 years, thereby, enhancing the diagnosis of eye diseases. However, the presence of other advanced technologies such as OCT for the diagnosis of eye problems is expected to hinder the adoption of fundus cameras and may impact the overall market growth during the forecast period.

Request a free sample copy or view report summary: Fundus Cameras Market Report

Fundus Cameras Market Report Highlights

The non-mydriatic fundus cameras segment dominated the market in 2020 due to increased demand, as it enables the practitioner to view the retinal anatomy in detail and provides enhanced diagnosis and management of eye diseases
Non-mydriatic and mydriatic camera can be further sub-segmented into tabletop and handheld. The tabletop segment dominated the market in 2020 because of the availability of a higher number of commercialized products and the ability to produce a better image quality than handheld products
By end use, the ophthalmic and optometrist offices segment is expected to grow at the fastest rate during the forecast period due to the availability of well-equipped offices in North America and Europe, and the preference of patients for primary eye care
North America dominated the market in 2020 and is expected to maintain its position during the forecast period, due to the local presence of major players and increased awareness about eye disorders
In Asia Pacific, the market is anticipated to be the fastest-growing segment during the forecast period due to rising healthcare expenditure and increasing cases of retinal detachment, DR, and AMD

Fundus Cameras Market Segmentation

Grand View Research has segmented the global fundus cameras market based on product, end-use, and region:

Fundus Cameras Product Outlook (Revenue, USD Million, 2016 - 2028)

Mydriatic Fundus Cameras
- Tabletop
- Handheld
Non-Mydriatic Fundus Cameras
- Tabletop
- Handheld
Hybrid Fundus Cameras
ROP Fundus Cameras

Fundus Cameras End-use Outlook (Revenue, USD Million, 2016 - 2028)

Hospitals
Ophthalmology Clinics
Ophthalmic & Optometrist Offices

Fundus Cameras Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Italy
- Spain
- The Netherlands
- Russia
- Switzerland
- Poland
- Turkey
Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Indonesia
- Taiwan
- Hong Kong
- Philippines
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Qatar

List of Key Players of Fundus Cameras Market

Carl Zeiss Meditec, Inc.
Kowa Company Ltd.
Optomed Oy (Ltd.)
Optovue, Incorporated
CenterVue SpA
NIDEK Co., Ltd.
Topcon Medical Systems, Inc.
Clarity Medical Systems, Inc.
Canon, Inc.

About Grand View Research

COVID-19 Detection Kits Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development 2027

COVID-19 Detection Kits Market Growth & Trends

The global COVID-19 detection kits market size is expected to reach USD 4.63 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.05% during the forecast period. The COVID-19 pandemic has posed several challenges to the global healthcare systems. The diagnostics area is recognized as one of the primary elements of efforts to contain the spread and circumvent its adverse impact globally. As a result, companies are ramping up their production process to meet the demand or kits and reagents as well as at-home tests, thereby driving the market revenue.

Constantly increasing demand for rapid diagnostic tests that can deliver results in less time coupled with a shortage of testing materials has triggered the development of antibody and antigen test kits. For instance, in August 2020, Abbott Laboratories secured approval for a COVID-19 portable antigen test that can deliver results in 15 minutes.

Despite the time and cost-related challenges, molecular assay remains the key detection method owing to high sensitivity and specificity. As a result, the kits for RT-PCR based molecular assay are witnessing a huge rise in demand across the globe. The continuous growth in the shipping of the molecular test kit depicts the high demand for these kits. For instance, in May 2020, Siemens Healthineers announced its plans to ship more than 2.5 million molecular PCR test kits per month.

Request a free sample copy or view report summary: COVID-19 Detection Kits Market Report

COVID-19 Detection Kits Market Report Highlights

RT-PCR assay kits are estimated to account for the major revenue share owing to the high usage rate of PCR testing. High reliability of test results is the key contributing factor of high adoption of RT-PCR assays across the globe
Nasopharyngeal (NP) swabs are estimated to capture maximum revenue share owing to the dependence of RT-PCR assays on NP swabs. Healthcare institutes and testing service providers have collaborated with market participants for the supply of NP swabs to test patients at a large scale
Centralized testing (Non-PoC) is currently the key mode of testing and thus it is anticipated to maintain its dominance through 2020. Through this mode, healthcare professionals can process a massive number of samples with great efficiency and a high level of automation, thereby driving the segment growth
In the current market, laboratories is the key revenue-generating end-user segment with a high number of a testing process taking place within laboratory settings
With a high number of cases and testing, Asia Pacific is anticipated to maintain its dominance throughout the forecast period. Asian countries are focusing on rapid antigen testing as a cost-effective strategy to contain the spread, resulting in the revenue growth of this region
Some of the key players operating in the COVID-19 detection kits industry include Quidel Corporation; Abbott; Becton, Dickinson and Company, and Thermo Fisher Scientific, Inc.

COVID-19 Detection Kits Market Segmentation

Grand View Research has segmented the global COVID-19 detection kits market on the basis of product, sample type, mode, end-use, and region:

COVID-19 Detection Kits Products Outlook (Revenue, USD Million, 2020 - 2027)

RT-PCR Assay Kits
Immunoassay Test Strips/Cassettes

COVID-19 Detection Kits Sample Type Outlook (Revenue, USD Million, 2020 - 2027)

Nasopharyngeal (NP) Swab
Oropharyngeal (OP) Swab
Nasal Swab
Others

COVID-19 Detection Kits Mode Outlook (Revenue, USD Million, 2020 - 2027)

Decentralized or Point-of-Care (PoC) Testing
Centralized Testing (Non-PoC)

COVID-19 Detection Kits End-use Outlook (Revenue, USD Million, 2020 - 2027)

Laboratories
Hospitals
Diagnostic Centers and Clinics
Others (Research Institutes & Direct-to-Consumers)

COVID-19 Detection Kits Regional Outlook (Revenue, USD Million, 2020 - 2027)

North America
- The U.S.
- Canada
Europe
- Germany
- The U.K.
- France
- Italy
- Spain
- Austria
- Portugal
- Sweden
- Norway
- Russia
- Denmark
- Poland
- Switzerland
- Turkey
- Belgium
- Netherlands
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Malaysia
- Philippines
- Indonesia
- Thailand
- Singapore
Latin America
- Brazil
- Chile
- Peru
- Mexico
The Middle East & Africa (MEA)
- South Africa
- Iran
- Israel
- UAE
- Qatar
- Iraq

List of Key Players of COVID-19 Detection Kits Market

Hoffman-La Roche Ltd.
Thermo Fisher Scientific, Inc.
Perkin Elmer, Inc.
Veredus Laboratories
DiaSorin
altona Diagnostics GmbH
Mylab Discovery Solutions Pvt Ltd
Abbott
Luminex Corporation
Quidel Corporation
Becton, Dickinson and Company

About Grand View Research

Market Research Size

Tuesday, 12 January 2021

Magnetic Resonance Imaging Market to Incur Meteoric Growth During 2021 to 2028: Grand View Research Inc.

Extracorporeal Membrane Oxygenation Machine Market is Thriving USD 398.6 Million Revenue by 2028

Monday, 11 January 2021

Medical Imaging Market Trends Regulations And Competitive Landscape Outlook to 2028

Aesthetic Medicine Market Industry Size, Driving Demands, and Industry Share of Various Stakeholders

Aesthetic Medicine Market Report Highlights

Aesthetic Medicine Market Segmentation

Neurothrombectomy Devices Market Expected to Deliver Dynamic Progression until By 2028

COVID-19 Clinical Trials Market Poised to Expand at a Robust Pace of USD 9.9 Billion Over 2027: Grand View Research Inc.

Ecotoxicological Studies Market to Reach Around USD 1.3 Billion by 2027: Grand View Research Inc.

Electric Bed Market is Anticipated To Generate Significant Revenues by 2027: Grand View Research Inc.

Sunday, 10 January 2021

Filter Needles Market Latest Innovations, Drivers and Industry Key Events 2021– 2027: Grand View Research Inc.

COVID-19 Drug Delivery Devices Market Pegged For Strong Growth During 2021-2027: Grand View Research Inc.

Friday, 8 January 2021

U.S. Medical Device Manufacturers Market Is Expected To Accomplish A Valuation Of Around USD 262.4 Billion By 2028: Grand View Research Inc.

End Stage Renal Disease Market to Reflect Robust Expansion During 2021-2028: Grand View Research Inc.

India Online Grocery Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

Fundus Cameras Market Competitive Insight and Key Drivers 2021 to 2028: Grand View Research Inc.

COVID-19 Detection Kits Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development 2027

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

Search This Blog